Overview
Autosomal dominant limb-girdle muscular dystrophy type 1H (LGMD1H) is an obsolete disease designation that was previously used to describe a form of limb-girdle muscular dystrophy inherited in an autosomal dominant pattern. Limb-girdle muscular dystrophies are a group of genetic disorders characterized by progressive weakness and wasting of the muscles of the hip and shoulder girdles (proximal muscles). LGMD1H was initially mapped to chromosome 3p25.1-p23 in a large Italian family presenting with proximal muscle weakness, elevated serum creatine kinase levels, and variable age of onset. Affected individuals typically experienced difficulty with activities such as climbing stairs, rising from a seated position, and raising the arms above the head. This designation has been rendered obsolete following the reclassification of limb-girdle muscular dystrophies under a revised nomenclature system. Under the updated classification proposed by Straub et al. (2018), many previously designated LGMD subtypes were reorganized, and some entries — including LGMD1H — were retired due to insufficient confirmation of the causative gene or because the underlying genetic basis was not definitively established. The disease entity may have been reclassified or merged with another recognized form of LGMD. Patients and families who were previously given this diagnosis are encouraged to seek updated genetic evaluation, as advances in next-generation sequencing may now allow identification of the specific causative gene. There is no specific treatment for this condition; management has historically been supportive, including physical therapy, assistive devices, and monitoring for cardiac and respiratory complications that can accompany some forms of LGMD.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H.
Start the conversation →Latest news about OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H
No recent news articles for OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H
What is OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H?
Autosomal dominant limb-girdle muscular dystrophy type 1H (LGMD1H) is an obsolete disease designation that was previously used to describe a form of limb-girdle muscular dystrophy inherited in an autosomal dominant pattern. Limb-girdle muscular dystrophies are a group of genetic disorders characterized by progressive weakness and wasting of the muscles of the hip and shoulder girdles (proximal muscles). LGMD1H was initially mapped to chromosome 3p25.1-p23 in a large Italian family presenting with proximal muscle weakness, elevated serum creatine kinase levels, and variable age of onset. Affect
How is OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H inherited?
OBSOLETE: Autosomal dominant limb-girdle muscular dystrophy type 1H follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.